On CNBC’s “Mad Money Lightning Round,” Jim Cramer said he is intrigued about Anavex Life Sciences Corp (NASDAQ:AVXL) because Biogen Inc (NASDAQ:BIIB) data doesn’t look that good. He sees it as a real spec, but he would stick with it.
Cramer is done with Chinese IPOs. He would sell Nio Inc – ADR (NYSE:NIO).
He doesn’t understand a short position in Upstart Holdings Inc (NASDAQ:UPST).
